Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
ケタミンパモエート及びその使用
Document Type and Number:
Japanese Patent JP7451538
Kind Code:
B2
Abstract:
Provided are pamoate salts of ketamine having a stoichiometry of 2:1 of ketamine to pamoate, including R, S-ketamine pamoate, S-ketamine pamoate, or R-ketamine pamoate, and crystalline or amorphous forms of the pamoate salts, and having excellent safety and properties for pharmaceutical applications. Also provided are pharmaceutical compositions including the pamoate salts of ketamine and their uses in treating a CNS disease or serving as an anesthetic.

Inventors:
Tokazu Hayashi
Bun'ei Jun
Chen Jia-nen
Application Number:
JP2021540341A
Publication Date:
March 18, 2024
Filing Date:
January 10, 2020
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
Alar Pharmaceuticals Inc.
International Classes:
C07C225/20; A61K31/14; A61K31/192; A61P11/06; A61P25/00; A61P25/04; A61P25/06; A61P25/08; A61P25/16; A61P25/18; A61P25/24; A61P25/28; A61P25/36; A61P27/16; C07C65/11
Domestic Patent References:
JP2014196292A
JP2011524409A
JP2003519698A
Foreign References:
WO2018122626A1
WO2013035892A1
WO2017167180A1
Other References:
川口洋子ら,医薬品と結晶多形,生活工学研究,2002年,Vol.4, No.2,p.310-317
"新医薬品の規格及び試験方法の設定について",医薬審発第568号,2001年05月01日
PHARM STAGE,2007年
高田則幸,創薬段階における原薬Formスクリーニングと選択,PHARM STAGE,Vol.6, No.10,2007年01月15日,p.20-25
山野光久,医薬品のプロセス研究における結晶多形現象への取り組み,有機合成化学協会誌,2007年,65(9),p.907-913
BYRN S,PHARMACEUTICAL SOLIDS: A STRATEGIC APPROACH TO REGULATORY CONSIDERATIONS,PHARMACEUTICAL RESEARCH,米国,KLUWER ACADEMIC PUBLISHERS,1995年07月01日
Attorney, Agent or Firm:
Norito Yamao
Yasushi Ochiai